Nadav Kidron - 18 Mar 2026 Form 3 Insider Report for Alpha Tau Medical Ltd. (DRTS)

Role
Director
Signature
/s/ Nadav Kidron
Issuer symbol
DRTS
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 19:04:07 UTC
Previous filing
18 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KIDRON NADAV Director 20 MAMILLA, JERUSALEM, ISRAEL /s/ Nadav Kidron 18 Mar 2026 0001351779

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DRTS Ordinary Shares 2,986 18 Mar 2026 Direct
holding DRTS Restricted Share Units 7,767 18 Mar 2026 Direct F1
holding DRTS Restricted Share Units 4,680 18 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DRTS Options 18 Mar 2026 Ordinary Shares 35,554 $2.79 Direct F3
holding DRTS Options 18 Mar 2026 Ordinary Shares 15,527 $6.41 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in monthly equal installments for a period of three years commencing May 12, 2025, subject to the Reporting Person's continued service.
F2 These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
F3 These are options to acquire ordinary shares, which options will vest in monthly equal installments for a period of three years commencing May 12, 2025, subject to the Reporting Person's continued service.
F4 These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.